233 related articles for article (PubMed ID: 8538371)
1. Diazepam pretreatment suppresses morphine withdrawal signs in the mouse.
Suzuki T; Tsuda M; Narita M; Funada M; Mizoguchi H; Misawa M
Life Sci; 1996; 58(4):349-57. PubMed ID: 8538371
[TBL] [Abstract][Full Text] [Related]
2. Effect of pretreatment with pertussis toxin on the development of physical dependence on morphine.
Funada M; Narita M; Suzuki T; Misawa M
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):88-95. PubMed ID: 8377845
[TBL] [Abstract][Full Text] [Related]
3. Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
Kamei J; Ohsawa M
Life Sci; 1997; 60(15):PL223-8. PubMed ID: 9096248
[TBL] [Abstract][Full Text] [Related]
4. Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system.
Funada M; Hara C; Wada K
Eur J Pharmacol; 2001 Nov; 430(2-3):277-81. PubMed ID: 11711043
[TBL] [Abstract][Full Text] [Related]
5. Cortical acetylcholine release is increased and gamma-aminobutyric acid outflow is reduced during morphine withdrawal.
Antonelli T; Beani L; Bianchi C; Rando S; Simonato M; Tanganelli S
Br J Pharmacol; 1986 Dec; 89(4):853-60. PubMed ID: 3814913
[TBL] [Abstract][Full Text] [Related]
6. Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
Mamiya T; Noda Y; Ren X; Hamdy M; Furukawa S; Kameyama T; Yamada K; Nabeshima T
Br J Pharmacol; 2001 Mar; 132(5):1111-7. PubMed ID: 11226142
[TBL] [Abstract][Full Text] [Related]
7. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C.
Ohsawa M; Kamei J
Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart.
González-Cuello A; Sánchez L; Hernández J; Teresa Castells M; Victoria Milanés M; Laorden ML
Eur J Pharmacol; 2007 Sep; 570(1-3):1-9. PubMed ID: 17601555
[TBL] [Abstract][Full Text] [Related]
9. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.
Madhavan A; He L; Stuber GD; Bonci A; Whistler JL
J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
Singh P; Sharma B; Gupta S; Sharma BM
Psychopharmacology (Berl); 2015 Jan; 232(2):465-75. PubMed ID: 25059539
[TBL] [Abstract][Full Text] [Related]
11. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
[TBL] [Abstract][Full Text] [Related]
12. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats.
Bongianni F; Carla V; Moroni F; Pellegrini-Giampietro DE
Br J Pharmacol; 1986 Jul; 88(3):561-7. PubMed ID: 3017487
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.
Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A
Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154
[TBL] [Abstract][Full Text] [Related]
15. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
16. Changes in [3H]-UK 14304 binding to alpha 2-adrenoceptors in morphine-dependent guinea-pigs.
Varani K; Beani L; Bianchi C; Borea PA; Simonato M
Br J Pharmacol; 1995 Dec; 116(8):3125-32. PubMed ID: 8719786
[TBL] [Abstract][Full Text] [Related]
17. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
Fuertes G; Laorden ML; Milanés MV
Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
[TBL] [Abstract][Full Text] [Related]
18. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
19. Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal.
Crawley JN; Laverty R; Roth RH
Eur J Pharmacol; 1979 Aug; 57(2-3):247-50. PubMed ID: 573692
[TBL] [Abstract][Full Text] [Related]
20. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
